ANGELA WILES: Open Payments
NPI 1689134157 · LEWISBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 50 payments from 10 companies in 2025. Trend: 2023 $918 · 2024 $524 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $357 |
| ABBVIE INC. | 14 | $208 |
| Vanda Pharmaceuticals Inc. | 5 | $146 |
| Alkermes, Inc. | 6 | $132 |
| E.R. Squibb & Sons, L.L.C. | 5 | $131 |
| Otsuka America Pharmaceutical, Inc. | 2 | $124 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, HETLIOZ, LYBALVI, Auvelity, ARISTADA.
Industry payments across TN — which companies pay providers there.
